Veradermics, Incorporated ( MANE) - Key Metrics
MANE Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.58 | -$0.36 | -$0.36 |
| 2026Q1 | $0 | -$0.73 | -$0.57 | -$0.57 |
| 2025Q4 | $0 | -$0.59 | -$0.63 | -$0.63 |
| 2025Q3 | $0 | $0 | $0 | $0 |
| 2024Q4 | $0 | -$0.03 | -$0.02 | -$0.02 |
MANE Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -52.99 |
| 2026Q1 | 0% | -19.73 |
| 2025Q4 | 0% | -12.42 |
| 2025Q3 | 0% | 0 |
| 2024Q4 | 0% | -293.09 |
MANE
Price: $112.71
52 week price:
Earnings Per Share: -2.65 USD
Exchange: NYQ
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 4.6 billion